デフォルト表紙
市場調査レポート
商品コード
1410898

再建用メッシュ市場:市場規模(セグメント別)、シェア、規制、償還、手技、予測(~2033年)

Reconstruction Meshes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

出版日: | 発行: GlobalData | ページ情報: 英文 | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
再建用メッシュ市場:市場規模(セグメント別)、シェア、規制、償還、手技、予測(~2033年)
出版日: 2023年12月19日
発行: GlobalData
ページ情報: 英文
納期: 即納可能 即納可能とは
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

再建用メッシュは、臓器やその他の組織を修復または支持するために使用される外科的に移植可能な織布シートです。メッシュは、合成材料および/または動物組織から生体工学的に作製されます。乳房再建市場は、患者の満足度の向上、コストの削減、手術による副作用の減少により劇的に拡大しています。乳房インプラントとともに修復メッシュを使用することは、乳房切除後の乳房再建の効果的な方法として台頭してきています。IBBR(インプラントを用いた乳房再建)手術における合成および生物学的メッシュの使用は、審美的な結果が改善されるため、将来的に需要が増加する可能性が高いです。乳房再建、骨盤臓器脱治療、尿失禁治療における合成メッシュの安全性と性能の継続的な向上は、全体的な市場価値の拡大に寄与すると思われます。

当レポートは、世界の再建用メッシュ市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。

目次

現在上市されている再建用メッシュと競合情勢

  • 主要な業界動向の洞察
  • 再建用メッシュのセグメント別総市場収益と2015年~2033年の市場展望
  • セグメント別の手技総数、個数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

  • 再建用メッシュ市場のSWOT分析
  • 再建用メッシュ市場に関する競合力学の洞察と動向
  • 国別の医療制度の概要
  • 国別の償還政策
  • 国別の医療技術に関する規制の状況
図表

List of Tables

Not Applicable

List of Figures

Not Applicable

目次

Abstract

Reconstruction Meshes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within General Surgery Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Reconstruction Meshes market for the year 2020 and beyond. Reconstruction Meshes are surgically implantable woven sheets that are used to repair or support organs and other tissues. The meshes are made either from synthetic material and/or bioengineered from animal tissues. The breast reconstruction market is increasing dramatically due to improvements in patient satisfaction, reduced costs, and decreases in side-effects from procedures. Use of repair meshes along with breast implants is emerging as an effective method for breast reconstruction after mastectomy. The demand for the use of synthetic and biologic meshes in IBBR (Implant based Breast Reconstruction) surgeries is likely to increase in the future because of the improved aesthetic outcome. Continued improvements in synthetic mesh safety and performance for breast reconstruction, pelvic organ prolapse treatment, and urinary incontinence treatments will contribute to their overall growth in market value.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Reconstruction Meshes and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Reconstruction Meshes market revenue by segment and market outlooks from 2015-2033.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Reconstruction Meshes market.
  • Competitive dynamics insights and trends provided Reconstruction Meshes market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: AbbVie Inc, W. L. Gore & Associates Inc, Donor Network West, Surgalign Holdings Inc, Coloplast A/S, Johnson & Johnson, Boston Scientific Corp, Becton Dickinson and Co, Integra LifeSciences Holdings Corp, pfm medical ag, Baxter International Inc, LifeNet Health Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Reconstruction Meshes market place to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Reconstruction Meshes.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Reconstruction Meshes.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Reconstruction Meshes market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Reconstruction Meshes market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable